Update on genetics and pathogenesis of autoinflammatory diseases: The last 2 years

Seminars in Immunopathology

Volumn 37, Issue 4, 2015, Pages 395-401

  Aksentijevich, Ivona ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

Autoinflammation; Deficiency ofADA2 (DADA2); LACC1 associated monogenic disease; Next generation sequencing (NGS); NLRC4 associated inflammatory diseases; STING associated vasculopathy with onset in infancy (SAVI); TRNT1 deficiency SIFD

Indexed keywords

CYTOKINE; CALCIUM BINDING PROTEIN; CASPASE RECRUITMENT DOMAIN SIGNALING PROTEIN; MEMBRANE PROTEIN; MPYS PROTEIN, HUMAN; NLRC4 PROTEIN, HUMAN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TADA2A PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ALLELE; AUTOINFLAMMATORY DISEASE; BONE MARROW CELL; CELL DIFFERENTIATION; DEFICIENCY OF ADA2; ENVIRONMENTAL FACTOR; ENZYME SUBSTRATE; GENE IDENTIFICATION; GENE MUTATION; GENETICS; GENOTYPE; HUMAN; INFLAMMATION; NEXT GENERATION SEQUENCING; NLRC4 ASSOCIATED INFLAMMATORY DISEASE; NONHUMAN; OXIDATION; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; STING ASSOCIATED VASCULOPATHY WITH ONSET IN INFANCY; SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS; TNFRSF11A ASSOCIATED HEREDITARY FEVER DISEASE; TRNT1 DEFICIENCY; AUTOIMMUNE DISEASES; DEFICIENCY; GENETIC ASSOCIATION STUDY; HEREDITARY AUTOINFLAMMATORY DISEASES; METABOLISM; ONSET AGE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AGE OF ONSET; AUTOIMMUNE DISEASES; CALCIUM-BINDING PROTEINS; CARD SIGNALING ADAPTOR PROTEINS; GENETIC ASSOCIATION STUDIES; HEREDITARY AUTOINFLAMMATORY DISEASES; HUMANS; INFLAMMATION; MEMBRANE PROTEINS; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; TRANSCRIPTION FACTORS;

EID: 84933548491     PISSN: 18632297     EISSN: 18632300     Source Type: Journal    
DOI: 10.1007/s00281-015-0478-4     Document Type: Review

References (48)

1. Ombrello MJ, Sikora KA, Kastner DL (2014) Genetics, genomics, and their relevance to pathology and therapy. Best Pract Res Clin Rheumatol 28:175–189
2. Zhou Q et al (2014) Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med 370:911–920
3. Navon Elkan P et al (2014) Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. N Engl J Med 370:921–931
4. Garg N et al (2014) Novel adenosine deaminase 2 mutations in a child with a fatal vasculopathy. Eur J Pediatr 173:827–830
5. van Montfrans J, Zavialov A, Zhou Q (2014) Mutant ADA2 in vasculopathies. N Engl J Med 371:478
6. Van Eyck L, Liston A, Meyts I (2014) Mutant ADA2 in vasculopathies. N Engl J Med 371:478–479
7. Bras J, Guerreiro R, Santo GC (2014) Mutant ADA2 in vasculopathies. N Engl J Med 371:478–480
8. Van Eyck L, Liston A, Wouters C (2014) Mutant ADA2 in vasculopathies. N Engl J Med 371:480
9. Zavialov AV, Yu X, Spillmann D, Lauvau G, Zavialov AV (2010) Structural basis for the growth factor activity of human adenosine deaminase ADA2. J Biol Chem 285:12367–12377
10. Iijima R et al (2008) The extracellular adenosine deaminase growth factor, ADGF/CECR1, plays a role in Xenopus embryogenesis via the adenosine/P1 receptor. J Biol Chem 283:2255–2264
11. Dolezal T, Dolezelova E, Zurovec M, Bryant PJ (2005) A role for adenosine deaminase in Drosophila larval development. PLoS Biol 3:e201
12. Zavialov AV et al (2010) Human adenosine deaminase 2 induces differentiation of monocytes into macrophages and stimulates proliferation of T helper cells andmacrophages. J Leukoc Biol 88:279–290
13. Belot A et al (2014) Mutations in CECR1 associated with a neutrophil signature in peripheral blood. Pediatr Rheumatol Online J 12: 44
14. Van Eyck L Jr et al 2015 Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency. J Allergy Clin Immunol 135:283–287, e5
15. Liu Y et al (2014) Activated STING in a vascular and pulmonary syndrome. N Engl J Med 371:507–518
16. Jeremiah N et al (2014) Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations. J Clin Invest 124:5516–5520
17. Burdette DL et al (2011) STING is a direct innate immune sensor of cyclic di-GMP. Nature 478:515–518
18. Barber GN (2014) STING-dependent cytosolic DNA sensing pathways. Trends Immunol 35:88–93
19. Burdette DL, Vance RE (2013) STING and the innate immune response to nucleic acids in the cytosol. Nat Immunol 14:19–26
20. Ishikawa H, Barber GN (2008) STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455:674–678
21. Zhang L et al (2014) NLRC3, a member of the NLR family of proteins, is a negative regulator of innate immune signaling induced by the DNA sensor STING. Immunity 40:329–341
22. Boyce BF, Xing L (2007) The RANKL/RANK/OPG pathway. Curr Osteoporos Rep 5:98–104
23. Walsh MC, Choi Y (2014) Biology of the RANKL-RANK-OPG system in immunity, bone, and beyond. Front Immunol 5:511
24. Soysa NS, Alles N, Aoki K, Ohya K (2012) Osteoclast formation and differentiation: an overview. J Med Dent Sci 59:65–74
25. Whyte MP (2006) Paget's disease of bone and genetic disorders of RANKL/OPG/RANK/NF-kappaB signaling. Ann N Y Acad Sci 1068:143–164
26. Hanada R et al (2009) Central control of fever and female body temperature by RANKL/RANK. Nature 462:505–509
27. Jeru I et al (2014) Brief Report: Involvement of TNFRSF11A molecular defects in autoinflammatory disorders. Arthritis Rheumatol 66:2621–2627
28. Anderson DM et al (1997) A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390:175–179
29. Dougall WC et al (1999) RANK is essential for osteoclast and lymph node development. Genes Dev 13:2412–2424
30. Canna SW et al (2014) An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome. Nat Genet 46:1140–1146
31. Romberg N et al (2014) Mutation of NLRC4 causes a syndrome of enterocolitis and autoinflammation. Nat Genet 46:1135–1139
32. Kitamura A, Sasaki Y, Abe T, Kano H, Yasutomo K (2014) An inherited mutation in NLRC4 causes autoinflammation in human and mice. J Exp Med 211:2385–2396
33. Franchi L et al (2006) Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages. Nat Immunol 7:576–582
34. Vance RE (2015) The NAIP/NLRC4 inflammasomes. Curr Opin Immunol 32C:84–89
35. Sellin ME et al (2014) Epithelium-intrinsic NAIP/NLRC4 inflammasome drives infected enterocyte expulsion to restrict Salmonella replication in the intestinal mucosa. Cell Host Microbe 16:237–248
36. Zhao Y et al (2011) The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature 477:596–600
37. Nordlander S, Pott J, Maloy KJ (2014) NLRC4 expression in intestinal epithelial cellsmediates protection against an enteric pathogen. Mucosal Immunol 7:775–785
38. Wiseman DH et al (2013) A novel syndrome of congenital sideroblastic anemia, B-cell immunodeficiency, periodic fevers, and developmental delay (SIFD). Blood 122:112–123
39. Chakraborty PK et al (2014) Mutations in TRNT1 cause congenital sideroblastic anemia with immunodeficiency, fevers, and developmental delay (SIFD). Blood 124:2867–2871
40. Sasarman F, et al (2015) The 3' addition of CCA to mitochondrial tRNASer(AGY) is specifically impaired in patients with mutations in the tRNA nucleotidyl transferase TRNT1. Hum Mol Genet
41. Xiong Y, Steitz TA (2006) A story with a good ending: tRNA 3'-end maturation by CCA-adding enzymes. Curr Opin Struct Biol 16:12–17
42. Cimaz R, Von Scheven A, Hofer M (2012) Systemic-onset juvenile idiopathic arthritis: the changing life of a rare disease. Swiss Med Wkly 142:w13582
43. Pascual V et al (2008) How the study of children with rheumatic diseases identified interferon-alpha and interleukin-1 as novel therapeutic targets. Immunol Rev 223:39–59
44. Pascual V, Allantaz F, Arce E, Punaro M, Banchereau J (2005) Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med 201:1479–1486
45. Wakil SM et al (2015) Association of a mutation in LACC1 with a monogenic form of systemic juvenile idiopathic arthritis. Arthritis Rheumatol 67:288–295
46. Wong SH, Hill AV, Vannberg FO, India-Africa-United Kingdom Leprosy Genetics, C (2010) Genomewide association study of leprosy. N Engl J Med 362:1446–7, author reply 1447-8
47. Zhang FR et al (2009) Genomewide association study of leprosy. N Engl J Med 361:2609–2618
48. Sales-Marques C et al (2014) NOD2 and CCDC122-LACC1 genes are associated with leprosy susceptibility in Brazilians. Hum Genet 133:1525–1532